With FDA approval of an investigational device exemption, J&J’s soft tissue robot moves a step closer to challenging ...

Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...

"We are honored to be recognized with the Prix Galien Award for Best Digital Health Solution," said Dr. Chris Mansi, CEO and co-founder at Viz.ai. “For many with HCM, the path to diagnosis and ...

GE Healthcare has added to its AI capabilities over the past two years, inking deals to buy software from Intelligent ...

Donald Trump’s election victory comes weeks after the FDA named a new leader for the medical device center and as the ...

CFO Joel Grade told investors Friday that Baxter expects an approximately $200 million hit to sales in the fourth quarter ...

Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced ...

On Wednesday, Republican candidate and former president Donald Trump was elected to the nation’s highest office for the ...

Insulet saw strong insulin pump adoption among new users with Type 2 diabetes following its recent FDA clearance, while ...

The lowered sales forecast, which analysts called a “shocking guidance update,” contributed to a 23% drop in the cancer ...

J&J is the third medtech company to gain U.S. approval for pulsed field ablation, a new atrial fibrillation treatment seeing rapid adoption.

CEO Bernd Montag said the company is well positioned for a “U.S. versus China situation” that could arise when Donald Trump ...